N
Patient 1
(B)(6). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CLEARLINK DUO-VENT CONTINU-FLO SOLUTION SET | SET, ADMINISTRATION, INTRAVASCULAR | BAXTER HEALTHCARE CORPORATION | FPA | NA | UC8519 | DR20A20051 | R | N |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2020-03-31 | 0 |
Patient 1
(B)(6). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
Patient 1
IT WAS REPORTED THAT TWO (2) CLEARLINK SYSTEM CONTINU-FLO SOLUTION SETS WERE SEVERED. THE CUT IN THE SET WAS DISCOVERED PRIOR TO PATIENT USE. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.